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(Senior Associate Editor)In my ﬁrst editorial as Editor-in-Chief of The American
Journal of Pathology (AJP) in January 2013,1 I introduced
new editorial leadership and made a commitment to work
tirelessly to once again make AJP the preeminent investiga-
tive pathology journal. The year has ﬂown by quickly, and
signiﬁcant progress has been maded a reboot of sortsd to
recapture the spirit of discovery and excitement that has
characterized AJP throughout its long existence.
Improved SOPs
AJP leadership and staffmadeamajor effort in 2013 to evaluate
and improve uponour standard operating procedures (SOPs) to
ensure that authors and their submissions were treated profes-
sionally and expeditiously. AJP hired additional staff and
realigned responsibilities to more efﬁciently shepherd manu-
scripts through the reviewprocess.Amore vigilant approach to
tardy reviewers and an emphasis on fair, but rapid, assessment
of reviewers’ commentsbyAssociateEditors and theEditor-in-
Chief led to a dramatic decrease in turnaround times for all
categories of articles. We are particularly pleased that the
average time to ﬁrst notiﬁcation for reviewed research articles,
our largest category of submissions, decreased from 42 days in
2012 to 34 days in 2013. For editorially rejected articles (those
determined by the Editors to be outside the scope of AJP or of
low publication priority), author notiﬁcation time declined
from 12 days in 2012 to less than 5 days in 2013. We continue
to assess and revise all aspects of editorial workﬂow with the
goal of providing AJP contributors and reviewers the best
possible experience.
Increased Impact
AJP strives to publish outstanding papers focused on the
molecular and cellular mechanisms of disease pathogenesis.Copyright ª 2014 American Society for Investigative Pathology.
Published by Elsevier Inc. All rights reserved.
http://dx.doi.org/10.1016/j.ajpath.2013.11.001The vast majority of such articles are in the format of Regular
Articles, containing previously unpublished data that critically
address a clearly stated scientiﬁc hypothesis. Such articles are
the foundation of AJP’s success andwill always remain its top
priority. Quality demands high standards, and as a conse-
quence, not allAJP submissions can be accepted.Althoughwe
do not employ an absolute number of manuscripts that we will
accept, throughout the last several years,AJP’s acceptance rate
for regular article submissionswasmore than 40%.All of these
accepted articles were worthy of publication; however, the
scientiﬁc scope of these articles varied tremendously. We
decided to take a more selective approach, and the number of
primary research articles published in the AJP has purpose-
fully declined. This past year, we continued to emphasize
quality, and the overall acceptance rate decreased to less than
30% of submissions. Of course, this has led to disappointment
for some authors whose submissions were not accepted, but
we hope that these investigatorswill remain loyal toAJP aswe
continue to enhance the impact of this publication.
The decision of which articles to accept or reject based on
publication priority is the most difﬁcult and subjective de-
cision faced by an editor. Luckily, these decisions are not
made in a vacuum, and we rely heavily on the expertise of
Associate Editors and accomplished reviewers. In particular,
the AJP Editorial Board has always included outstanding
scientists and investigative pathologists who have served the
journal’s mission well. However, Editorial Board turnover
had been low in recent years, and in evaluating its roster, we
felt that additional diversity in experience, scientiﬁc focus,
and expertise was warranted. In 2013, we rotated off
approximately one-fourth of the members to allow other
scientists an opportunity to participate and to promote the
careers of junior and mid-career investigative pathologists.
We plan to impose more strict term limits on Editorial Board
membership in the future and to more regularly re-invigorate
Editorialthe Associate Editor and Editorial Board roster to achieve a
balance of experienced wisdom and youthful enthusiasm. At
the same time, we will encourage former Associate Editors
and Editorial Board members to remain active participants in
the AJP as authors and reviewers.
Evolving Scope
In recent years, new tools have emerged in the realms of Omics
and disease classiﬁcation, yielding technological advances to
facilitate such explorations in nonconventional yet insightful
ways. AJP continues to adapt to the changing methodological
landscape and research environment by evolving its scientiﬁc
scope in response to novel and thought-provoking data that
challenge previously accepted diagnostic criteria and disease
classiﬁcations. Such a scope shift has occurred in response to
hypothesis-generating research that sets the stage for the design
of critical hypothesis-testing experiments that challenge
investigative pathologists to develop new experimental models
and creative approaches. At AJP we have set the bar high for
non-traditional descriptive investigations of disease pathogen-
esis, but we welcome all manuscripts with the potential to drive
advances in all aspects of experimental pathology.
As a further consequence to its evolving scope, AJP strives
to increase the number of published review articles. Well
written Reviews by leading investigators document mile-
stones of past accomplishments and elucidate new directions
for future progress. Rapid changes in our understanding of
disease mechanisms, evolving concepts in systems biology,
and new informatics approaches to disease classiﬁcation and
diagnosis deserve special attention, and we will attempt to
highlight these and other advances in future AJP Reviews.
This past year we were pleased to publish two theme issues of
review content on Small Animal Imaging2 in February 2013,
organized by AJP Associate Editor and Special Editor Dr.
Herbert B. Tanowitz, and Breast Cancer3 in October 2013,
organized by Special Editor Dr. William B. Coleman. Look
to the February 2014 issue for the Liver Pathobiology Theme
Issue, curated by AJPAssociate Editor and Special Editor Dr.
Satdarshan P.S. Monga.
Enhanced Visibility
The AJP has made efforts to increase the visibility of the
Journal. Commentaries and news releases continue to focusThe American Journal of Pathology - ajp.amjpathol.orgattention on impactful research published in AJP. In
addition, each month we select two Regular Articles for
immediate free access. These Editor’s Choice articles
represent scientiﬁcally interesting manuscripts that should
appeal to a broad audience. Since review articles often
appeal to readers wishing to gain insights into a rapidly
developing ﬁeld, all of our Reviews, Mini-Reviews, Per-
spectives, and Editorials are immediately accessible to
online readers.
This past summer, AJP began delivering information and
content to its readers in a variety of new formats. Elsevier
launched a free app for the iPad, which enables anyone to view
the Table of Contents and article abstracts, and subscribers can
access the complete content (http://ajp.amjpathol.org/content/
mobileaccessinstructions). AJP also made its debut on Face-
book (https://www.facebook.com/AJPathology) and on Twitter
(@AJPathology). Both forums offer frequent posts that alert
followers to new issues of AJP, free articles, timely research
papers, and events and information of interest to experimental
pathologists and anyone interested in disease mechanisms.
Well over 100 people follow AJP on Twitter, more than 500
people ‘like’ AJP’s Facebook page, and authors are notiﬁed
when their papers are featured. Subsequent sharing of posts has
resulted in some articles reaching almost 1000 individuals.
We view our foray into social media as a way to increase the
visibility of AJP, to showcase the outstanding work of the
journal’s authors, and to provide an online community for re-
searchers in investigative pathology.Closing
In total, the AJP has made great progress over the last year,
and we look forward to 2014 ﬁlled with exciting science and
interesting articles. We hope you are as excited as we are
about AJP version 2.014. Your continued support and in-
volvement with the Journal is much appreciated.References
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